Can-Fite BioPharma CANF
NYSE CANF
$2.24 +0.04 (+1.82%)
As of: Oct 1, 2026 · 3:59 PM EDT

Can-Fite BioPharma (CANF) EPS (Diluted) (2020 - 2023)

Updated

Can-Fite BioPharma (CANF) recorded EPS (Diluted) of -$11.94 in FY2025, compared with -$0.14 in FY2024.

Analysis

Can-Fite BioPharma (CANF) EPS (Diluted) (2020 - 2023) Analysis & Trends

Starting with FY2020, Can-Fite BioPharma's EPS (Diluted) history includes 6 years.

  • The FY2025 figure is the lowest annual EPS (Diluted) in data going back to FY2020.
  • Per Business Quant data, CANF's EPS (Diluted) was -$0.14 in FY2024, -$0.24 in FY2023, -$0.37 in FY2022 and -$0.73 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.27
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.04
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -0.54
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.67
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.85
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.37
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -8.44
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 4.31
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -0.05
Sep 30, 2023 -0.09
Jun 30, 2023 0.12
Mar 31, 2023 -0.13
Dec 31, 2022 -0.02
Sep 30, 2022 -0.18
Jun 30, 2022 0.18
Mar 31, 2022 -0.18
Dec 31, 2021 -0.30
Sep 30, 2021 -0.38
Jun 30, 2021 -0.36
Mar 31, 2021 -0.21
Dec 31, 2020 -0.41
API Access

Can-Fite BioPharma EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=CANF&period=max&api_key=YOUR_API_KEY